Neurol. praxi. 2020;21(6):491-494

Susac's syndrome

MUDr. Jiří Pi»ha, MUDr. Marta Vachová, MUDr. Jana Kotalová, MUDr. Markéta Ceé
MS centrum při Neurologickém oddělení KZ, a. s. - Nemocnice Teplice, o. z., Teplice

Susac's syndrome (SS) is an autoimmune disease characterized by the clinical triad of encephalopathy, arterial retinal occlusion, and neurosensory hearing loss based on microangiopathy affecting the precapillary arterioles of the brain, retina and inner ear. SS is characterized by a typical radiological finding on MRI, which, together with clinical symptoms, may allow diagnosis. Retinal artery occlusion is best evaluated by fluorescein angiography, which may exhibit typical multifocal fluorescence. SS is an autoimmune endothelopathy that requires long-term treatment with corticosteroids, immunosuppressants, or even monoclonal antibodies, in acute cases intravenous immunoglobulin or plasmapheresis. Therapy leads to significant clinical and radiological improvement. Early diagnosis and treatment is important for delaying disease progression and preventing permanent disability. The article is illustrated by a case report of a woman with typical SS manifestations.

Keywords: Susac´s syndrome, encephalopathy, branch retinal artery occlusion, sensorineural hearing loss.

Published: January 6, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pi»ha J, Vachová M, Kotalová J, Ceé M. Susac's syndrome. Neurol. praxi. 2020;21(6):491-494.
Download citation

References

  1. Algahtani H, Shirah B, Amin M, Altarazi E, Almarzouki H. Susac Syndrome Misdiagnosed as Multiple Sclerosis With Exacerbation by Interferon Beta Therapy. Neuroradiol J 2018; 31(2): 207-212. Go to original source... Go to PubMed...
  2. Bitra RK, Eggenberger E. Review of Susac syndrome. Curr Opin Ophthalmol 2011; 22: 472-476. Go to original source... Go to PubMed...
  3. Bucciarelli S, Cervera R, Martínez M, Latorre X, Font J. Susac's syndrome or catastrophic antiphospholipid syndrome. Lupus 2004; 13: 607-608. Go to original source... Go to PubMed...
  4. Deane KD, Tyler KN, Johnson DW, Tanabe JL, Oskarrson BE, Nitka EE, Brass E, Davies JK, Striebich ChC. Susac syndrome and pregnancy: disease management. J Clin Rheumatol Mar 2011; 17(2): 83-88. Go to original source... Go to PubMed...
  5. Dörr J, Jarius S, Wildemann B, Ringelstein EB, Schwindt W, Deppe M, Wandinger KP, Promesberger J, Paul F, Kleffner I. Susac syndrome: an interdisciplinary challenge. Nervenarzt 2011; 82: 1250-1263. Go to original source... Go to PubMed...
  6. Dörr J, Krautwald S, Wildemann B, Jarius, S, Ringelstein M, Duning T, Aktas O, Ringelstein EB, Friedmann P, Kleffner I. Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol 2013; 9(6): 307-316. Go to original source... Go to PubMed...
  7. García-Carrasco M, Jiménez-Hernández C, Jiménez-Hernández M, Mendoza-Pinto C, Ramos-Alvarez G, Montiel-Jarquin A, Rojas-Rodríguez J, Cervera R. Susac's syndrome: an update. Autoimmun Rev 2011; 10: 548-552. Go to original source... Go to PubMed...
  8. Jarius S, Neumayer B, Wandinger KP, Hartmann M, Wildemann B. Anti-endothelial serum antibodies in a patient with Susac's syndrome. J Neurol Sci 2009; 285: 259-261. Go to original source... Go to PubMed...
  9. Kleffner I, Duning T, Lohmann H, Deppe M, Basel T, Promesberger J, Dörr J, Schwindt W, Ringelstein EB. A brief review of Susac syndrome. J Neurol Sci 2012; 322: 35-40. Go to original source... Go to PubMed...
  10. Mateen FJ, Zubkov AY, Muralidharan R, Fugate JE, Rodriguez FJ, Winters JL, Petty GV. Susac syndrome: clinical characteristics and treatment in 29 new cases. Eur J Neurol 2012; 19(6): 800-811. Go to original source... Go to PubMed...
  11. O'Halloran HS, Pearson PA, Lee WB, Susac JO, Berger JR. Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature. Ophthalmology 1998; 105: 1038-1044. Go to original source... Go to PubMed...
  12. Patel VA, Dunklebarger M, Zacharia TT, Isildak H. Otologic Manifestations of Susac Syndrome. Acta Otorhinolyryngol Ital 2018; 38 (6): 544-553. Go to original source... Go to PubMed...
  13. Pawate S, Agarwal A, Moses H, Sriram S. The spectrum of Susac'syndrome. Neurol Sci 2009; 30: 59-64. Go to original source... Go to PubMed...
  14. Rennebohm RM, Susac JO. Treatment of Susac's syndrome. J Neurol Sci 2007; 257: 215-220. Go to original source... Go to PubMed...
  15. Rennebohm RM, Susac JO. Treatment of Susac's syndrome.Curr Treat Options Neurol 2008; 10: 67-74. Go to original source... Go to PubMed...
  16. Rennebohm RM, Asdaghi N, Srivastava S, Gertner E. Guidelines for treatment of Susac syndrome - an update. Int J Stroke 2018; 1747493017751737. Go to original source... Go to PubMed...
  17. Saenz R, Quan AW, Magalhaes A, Kish K. MRI of Susac's syndrome. AJR Am J Roentgenol 2005; 184: 1688-1690. Go to original source... Go to PubMed...
  18. Saw VPJ, Canty PA, Green CM, Briggs RJ, Cremer PD, Harrisberg B, McCluskey P, O'Day J, Paine M, Wakefield D, Watson JD. Susac syndrome: Microangiopathy of the retina, cochlea and brain. Clin Exp Ophthalmol 2000; 28: 373-381. Go to original source... Go to PubMed...
  19. Susac JO, Hardman JM, Selhorst JB. Microangiopathy of the brain and retina. Neurology 1979; 29: 313-316. Go to original source... Go to PubMed...
  20. Vishnevskia-dai V, Chapman J, Sheinfeld R, Sharon T, Huna-Baron R, Manor RS, Shoenfeld Y, Zloto O. Susac syndrome: clinical characteristics, clinical classification, and longterm prognosis. Medicine (Baltimore) 2016; 95: e5223. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.